Total trials
122
Active
32
Phase 3
0
Total enrollment
12,220
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Multimodal pelviperineal physioterapy group | — | — | — | — | — | 1 |
Next readouts
- 2027-12-31
Top conditions
- Neck Pain10
- Shoulder Pain9
- Low Back Pain7
- Pelvic Floor Disorders5
- Myofascial Pain Syndrome3
- Knee Injuries3
- Temporomandibular Disorder3
- Caffeine3
Frequently asked questions about University of Alcala
- How many clinical trials does University of Alcala have on ClinicalTrials.gov?
- University of Alcala is listed as the lead sponsor on 122 clinical trials in ClinicalTrials.gov, 32 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Alcala's trials are in Phase 3?
- 0 of University of Alcala's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does University of Alcala focus on?
- University of Alcala's most-studied conditions on ClinicalTrials.gov are Neck Pain, Shoulder Pain, Low Back Pain, Pelvic Floor Disorders, Myofascial Pain Syndrome.
- When are University of Alcala's next clinical trial readouts?
- University of Alcala has 1 upcoming primary-completion readout tracked here; the soonest is “Genitourinary Syndrome of Menopause in Breast Cancer”, expected around 2027-12-31.